Intelligent risk communication: Can it be improved?

Drug Safety

Volumn 31, Issue 1, 2008, Pages 1-6

  Czarnecki, Andrzej ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Drug information; Pharmaceutical risk management; Pharmacovigilance; Regulatory process

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIURETIC AGENT; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PRACTOLOL; WARFARIN;

ADVERSE OUTCOME; BLEEDING; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; DRUG SAFETY; GOVERNMENT; HEALTH CARE PERSONNEL; HORMONE SUBSTITUTION; INTERPERSONAL COMMUNICATION; LAWYER; MEDICAL PRACTICE; MEDICAL SCHOOL; NOTE; PHYSICIAN; PRIORITY JOURNAL; PUBLISHING; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCIENTIST; STROKE;

EID: 37549037421     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831010-00001     Document Type: Note

References (40)

1. Guidance for industry premarketing risk assessment. Rockville (MD): FDA [online]. Available from URL: http://www.fda.gov/cder/guidance/6357fnl.htm [Accessed 2007 Oct 19]
2. ICH topic E2E: pharmacovigilance planning. 2005 Jun. EMEA [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/ich/571603en.pdf [Accessed 2007 Oct 19]
3. Guideline on pharmacovigilance for medicinal products for human use. requirement for risk management system. European Commission [online]. Available from URL: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-9/pdf/ vol9A_2007-04.pdf [Accessed 2007 Nov 27]
4. Yeong-Liang L, Chien-Hua W, Arnold CK. Simplified controlled studies in new regions for safety concern arising from using foreign safety data. Drug Inf J 2006; 40: 365-9
5. Dawber TR, Meadors GF, Moore FEJ. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951; 41: 279-86
6. Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. BMJ 1975 Mar 15; 1 (5958): 595-8
7. Erice declaration, 1997. Uppsala Monitoring Centre (UMC) [online]. Available from URL: http://www.who-umc.org/DynPage.aspx?.id=22690 [Accessed 2007 Oct 19]
8. Hugman B. The Erice declaration: the critical role of communication in drug safety. Drug Saf 2006; 29: 91-3
9. Erice manifesto: for global reform of the safety of medicines in patient care. 2006. Uppsala Monitoring Centre (UMC) [on-line]. Available from URL: http://www.who-umc.org/graphics/13286.pdf [Accessed 2007 Oct 19]
10. Leitch S. Skills in the UK: the long-term challenge. HM Treasury [online]. Available from URL: http://www.hm-treasury.gov.uk/independent_reviews/ leitch_review/review_leitch_index.cfm [Accessed 2007 Oct 19]
11. Literacy changes lives [online]. Available from URL: http:www. literacytrust.org.uk/Database/stats/adultstats.html [Accessed 2007 Nov 27]
12. Illiteracy on the rise in America [online]. Available from URL: http://www.wsws.org/news/1998/oct1998/ill-o14.shtml [Accessed 2007 Nov 27]
13. Manson JE, Allison MA, Rossouw JE, et al. for the WHI and WHI-CACS Investigators. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007 Jun 21; 356: 2591-602
14. Barrett-Connor E, Mosca L, Collins P, et al. for the Raloxifene Use for The Heart (RUTH) trial Investigators. Effects of raloxifene on cardiovascular events and breast cancer in post-menopausal women. N Engl J Med 2006 Jul 13; 355: 125-37
15. Jick H, Vasilakis C, Weinrauch LA, et al. A population-based study of users of appetite-suppressant drugs on the risk of cardiac valve regurgitation. N Engl J Med 1998; 339: 719-24
16. Silvestry FE, St John Sutton MS. Anorectic therapy and valvular heart disease. Eur Heart J 1999; 20: 17-20
17. Devereux RB. Appetite suppressants and valvular heart disease. N Engl J Med 1998; 339: 765-7
18. Schiller NB. Fen/phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't. J Am Col Cardiol 1999; 34: 1159-62
19. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. JAMA 2002; 288: 321-33
20. Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative Observational Study. JAMA 2002; 288: 980-7
21. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative. Arch Intern Med 2006, 166, 357-36
22. Baron JA. Can aspirin keep mortality at bay? Arch Intern Med 2007; 167: 535-6
23. Hauben M, Reich L, Gerrits CM, et al. Illusions of objectivity and a recommendation for reporting data mining results. Eur J Clin Pharmacol 2007; 63: 517-21
24. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300
25. Benefit-risk balance for marketed drugs: evaluating safety signals. Report of CIOMS Working Group IV. Geneva: CIOMS, 1998
26. Report of the CHMP Working Group on Benefit-Risk Assessment Models and Methods. London: EMEA, 2007 Jan 19. Report no.: EMEA/CHMP/15404/2007
27. Salek S, Musson F. Risk/benefit assessment in medicine. Chichester: Wiley & Sons, in press
28. Mussen F, Salek S, Walker S, et al. A quantitative approach to risk benefit assessment: part 2. The practical application of a new model [published erratum appears in Pharmacoepidemiol Drug Saf 2007 Aug; 16 (8): 946]. Pharmacoepidemiol Drug Saf 2007; 16 Suppl. 1: S16-41
29. Hourihane JO, Dean TP, Warner JO. Peanut allergy in relation to heredity, maternal diet, and other atopic diseases: results of a questionnaire survey, skin prick testing, and food challenges. BMJ 1996; 313: 518-21
30. Teenager with peanut allergy dies after a kiss. CTV.ca [online]. Available from URL: http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/ 20051125/peanut_allergy_051125/20051125 [Accessed 2007 Oct 23]
31. Daily Mail. Family tragedy as mother killed by tomato allergy [online]. Available from URL: http://www.dailymail.co.uk/pages/live/articles/health/ healthmain.html?in_article_id=331821&in_page_id=1774 [Accessed 2007 Nov 27]
32. Peanut allergy death. 2007 Nov 27. Dr Andy [online]. Available from URL: http://doctorandy.blogspot.com/2005/11/peanut-allergy-death.html [Accessed 2007 Oct 23]
33. Howard RL, Avery AJ, Salvenberg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharm 2006; 53: 136-47
34. Wilkie P. Patients reporting of adverse drug reactions. DIA Forum 2006; 42: 21-3
35. Bhathena RK. The 1995 pill scare and its aftermath lessons learnt. J Obstet Gynaecol. 1998; 18: 216-7
36. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry 2007; 164: 1029-34
37. Gibbons RD, Brown CH, Hur K, et al. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry 2007; 164: 1044-9
38. Metformin tablets BP: are there any side effects? [online]. Available from URL: http://www.emc.medicines.org.uk/emc/industry/default.asp?page= desplaydoc.asp&doc [Accessed 2007 Nov 27]
39. US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER). Guidance: drug safety information. FDA's communication to the public. FDA CDER, 2007 Mar. FDA [online]. Available from URL: http://www.fda.gov/cder/guidance/7477fnl.pdf [Accessed 2007 Oct 23]
40. Guideline on handling of direct healthcare profession communications on the safe and effective use of medicinal products for human use. Draft for public consultation, 2006 May. European Commission [online]. Available from URL: http://ec.europa.eu/enterprise/pharmaceuticals/pharmacos/docs/doc2006/05_2006/ draft_dhcp_guideline.pdf [Accessed 2007 Oct 23]